Abstract
Most patients with chronic renal failure(CRF) will receive an anesthetic, either for vascular access before hemodialysis or at the time of renal transplantation. Many have disseminated systemic disease, which increases the problems of anesthesia. The purpose of the present chapter is to review the major obstacles to safe anesthesia, to describe the modification in the activity of anesthetic drugs induced by renal failure, and to recommend safe approaches to anesthesia in the functionally anephric patient. Most patients are now dialyzed within 48 hours of transplantation so that severe cardiovascular and biochemical disturbances are seldom observed at the time of surgery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Vandam LD, Harrison JH, Murray JE, Merrill JP: Anesthetic aspects of renal homotransplantation in man. Anesthesiology 23:783–789, 1962.
Strunin L: Some aspects of anaesthesia for renal homotransplantation. Br J Anaesth 38:812–822, 1966.
Bastron RD, Bailey G, Deutsch S, Vandam LD: Anesthesia for patients with chronic renal failure for renal homotransplantation. Anesthesiology 30:335–336, 1969.
Samuel JR, Powell D: Renal transplantation. Anaesthetic experience of 100 cases. Anaesthesia 25:165–176, 1970.
Monks PS, Lumley H: Anaesthetic aspects of renal transplantation. Ann Coll Surg Engl 50:354–366, 1972.
Slawson KB: Anaesthesia for the patient in renal failure. Br J Anaesth 44:277–282, 1972.
Logan DA, Howie HB, Crawford J: Anaestheia for renal transplantation: An analysis of fifty-six cases. Br J Anaesth 46:69–72, 1974.
Uldall PR, Wilkinson R, Dewar PJ, et al.: Factors affecting the outcome of cadaver renal transplantation in Newcastle upon Tyne. Lancet 2:316–319, 1977.
Kowalyshyn TJ, Prager D, Young J: A review of the present status of preoperative hemoglobin requirements. Anesth Analg 51:75–80, 1972.
Gillies IDS: Anaemia and anaesthesia. Br J Anaesth 46:589–602, 1974.
Prys-Roberts C, Meloche R, Foex P: Studies of anaesthesia in relation to hypertension. I. Cardiovascular responses of treated and untreated patients. Anesthesiology 50:285–292, 1979.
Goldman L, Caldera DL: Risks of general anesthesia and elective operation in the hypertensive patient. Anesthesiology 50:285–292, 1979.
Cronnelly R, Kremer PF, Beaupre P, Cahalan MK, Salvatierra O, Feduska N: Hemodynamic response to fluid challenge in anesthetized patients with end-tidal renal disease. Anesthesiology 59:A49, 1983.
Carlier M, Squifflet J-P, Pirson Y, Gribomont B, Alexandre GPJ: Maximal hydration during anesthesia increases pulmonary arterial pressures and improves early function of human renal transplants. Transplantation 34:201–204, 1982.
Tasker PRW, MacGregor GA, de Wardener HE: Prophylactic use of intravenous saline in patients with chronic renal failure undergoing major surgery. Lancet 2:911–912, 1974.
Eiser AR: Pulmonary gas exchange during hemodialysis and peritoneal dialysis: Interaction between respiration and metabolism. Am J Kidney Dis 6:131–142, 1985.
Goggin MJ, Joekes AM: Gas exchange in renal failure. I. Dangers of hyperkalaemia during anaesthesia. Br Med J 2:244–247, 1971.
Koide M, Waud BE: Serum potassium concentrations after succinylcholine in patients with renal failure. Anesthesiology 36:142–144, 1972.
Soulillou JP, Fillaudeau F, Keribin JP, Guenel J: Acute hyperkalemia risks in recipients of kidney graft cooled with Collins’ solution. Nephron 19:301–304, 1977.
McNamee PT, Moore GW, McGeown MG, Doherty CC, Collins BJ: Gastric emptying in chronic renal failure. Br Med J 291:310–311, 1985.
Azar I: The response of patients with neuromuscular disorders to muscle relaxants: A review. Anesthesiology 61:173–187, 1984.
Symreng T, Karlberg BR, Kagedal B, Schildt B: Physiological Cortisol substitution of long-term steroid-treated patients undergoing major surgery. Br J Anaesth 53:949–954, 1981.
Sokoll MD, Gergis SD: Antibiotics and neuromuscular function. Anesthesiology 55:148–159, 1981.
Salaman JR, Calne RY, Pena J, Sells RA, White HJO, Yoffa D: Surgical aspects of clinical renal transplantation. Br J Surg 56:413–417, 1969.
Don HF, Dieppa RA, Taylor P: Narcotic analgesics in anuric patients. Anesthesiology 42:745–747, 1975.
Ghoneim MM, Pandya H: Plasma protein binding of thiopental in patients with impared renal or hepatic function. Anesthesiology 42:545–549, 1975.
Richet G, de Novales EL, Verroust P: Drug intoxication and neurological episodes in chronic renal failure. Br Med J 2: 394–395, 1970.
Freeman RB, Sheff MF, Maher JF, Schreiner GE: The blood cerebrospinal fluid barrier in uremia. Ann Intern Med 56: 233–240, 1962.
Hobika GH, Evers JL, Mostert JW, Trudnowski RJ, Moore RH, Murphy GP: Comparison of hemodynamic effects of glucagon and ketamine in patients with chronic renal failure. Anesthesiology 37:654–658, 1972.
Crandell WB, Pappas SG, Macdonald A: Nephrotoxicity associated with methoxyflurane anesthesia. Anesthesiology 27:591–595, 1966.
Cousins MJ, Mazze RI: Methoxyflurane nephrotoxicity. A study of dose response in man. JAMA 225:1611–1614, 1973.
Mazze RI, Woodruff RE, Heerdt ME: Isoniazid-induced enflurane defluorination in humans. Anesthesiology 57:5–8, 1982.
Miller MS, Gandolfi AJ, Vaughan RW, Bentley JB: Disposition of enflurane in obese patients. J Pharmacol Exp Ther 215:292–296, 1980.
Rice SA, Fish KJ: Anesthetic metabolism and renal function in obese and nonobese Fischer 344 rats following enflurane or isoflurane anesthesia. Anesthesiology 65:28–34, 1986.
de Temmerman P, Gribomont B: Enflurane in renal transplantation: Report of 375 cases. Acta Anaesthesiol Scand 71 (Suppl):24–31, 1979.
Wickstrom I: Effects of enflurane anesthesia on the function of ischemically damaged kidneys. Acta Anaesthesiol Scand 71 (Suppl):15–19, 1979.
Bastron RD: Anesthetic considerations in patients with renal disease. ASA Refresher Courses 128:1–4, 1981.
Mostert JW, Evers JL, Hobika GH, Moore RD, Murphy GP: Circulatory effects of analgesic and neuroleptic drugs in patients with chronic renal failure undergoing maintenance dialysis. Br J Anaesth 42:501–505, 1970.
Kay B: Antidiuretic effects of anaesthesia and neurolept-anaesthesia (NLA). In WF Henschel, ed, International Bremer NLA Symposium. Schattaner Verlag, Stuttgart, p 135, 1975.
Holmes JH, Makamoto S, Sawyer KC: Changes in blood composition before and after dialysis with the Kalff twin coil kidney. Trans Am Soc Artif Intern Organs 4:16–18, 1958.
Ryan DW: Postoperative serum Cholinesterase activity following successful renal transplantation. Br J Anaesth 51:881–884, 1979.
Dretchen KL, Morgenroth VH, Standaert FG, Walts LF: Azathioprine: Effects on neuromuscular transmission. Anesthesiology 45:604–609, 1976.
Ramzan MI, Shanks CA, Triggs EJ: Gallamine disposition in surgical patients with chronic renal failure. Br J Clin Pharmacol 12:141–147, 1981.
Feldman SA, Levi JA: Prolonged paresis following gallamine: A case report. Br J Anaesth 35:804–806, 1963.
Singer MM, Dutton R, Way WL: Untoward results of gallamine administered during bilateral nephrectomy: Treatment with haemodialysis. Br J Anaesth 43:404–407, 1971.
Lebrault C, Berger JL, D’Hollander AA, Gomeni R, Henzel D, Duvaldestin P: Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC 45) in patients with cirrhosis. Anesthesiology 62:601–605, 1985.
Fahey MR, Rupp SM, Fisher DM: The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure. Anesthesiology 61:699–702, 1984.
Hunter JM, Jones RS, Utting JE: Use of atracurium in patients with no renal function. Br J Anaesth 54:1251–1258, 1982.
Stenlake JB, Waugh RD, Dewar GH, Hughes R, Chappel DJ, Coker GG: Biodegradable neuromuscular blocking agents. Part 4. Atracurium besylate and related polyalkylene di-esters. Eur J Med Chem 16:515–524, 1981.
Nigrovic V, Pandya JB, Auen M, Wajskol A: Inactivation of atracurium in human and rat plasma. Anesth Analg 64:1047–1052, 1985.
Bevan DR, Donati F, Gyasi H, Williams A: Vecuronium in renal failure. Can Anaesth Soc J 31:491–496, 1984.
Somogyi AA, Shanks CA, Triggs EJ: The effect of renal failure on the disposition and neuromuscular blocking action of pancuronium bromide. Eur J Clin Pharmacol 12:23–29, 1977.
Fahey MR, Morris RB, Miller RD, Nguyen T-L, Upton RA: Pharmacokinetics of ORG NC45 (Norcuron) in patients with and without renal failure. Br J Anaesth 53:1049–1053, 1982.
Miller RD, Stevens WS, Way WL: The effect of renal failure on the duration of pancuronium neuromuscular blockade in man. Anesth Analg 52:661–665, 1973.
Fahey MR, Morris RB, Miller RD, Sohn YJ, Cronnelly R, Gencarelli P: Clinical pharmacology of ORG NC45 (Norcuron). Anesthesiology 55:6–11, 1981.
Shanks CA: Pharmacokinetics of the non-depolarizing neuromuscular relaxants applied to calculation of bolus and infusion dose regimens. Anesthesiology 64:72–86, 1986.
Cronnelly R, Stanski DR, Miller RD, Sheiner LB, Soh YJ: Renal function and the pharmacokinetics of neostigmine in anesthetized man. Anesthesiology 51:222–226, 1979.
Morris RB, Cronnelly R, Miller RD, Stanski DR, Fahey MR: Pharmacokinetics of edrophonium in anephric and renal transplant patients. Br J Anaesth 53:1311–1314, 1981.
Rennick BR: Renal tubule transport of organic cations. Am J Physiol 9:F83–F89, 1981.
Bevan DR, Archer DP, Donati F, Ferguson A, Higgs BD: Reversal of pancuronium in renal failure: No recurarisation. Br J Anaesth 54:63–68, 1982.
Bromage PR, Gertel M: Brachial plexus anesthesia in chronic renal failure. Anesthesiology 36:488–493, 1972.
Beauregard L, Martin R, Tetrault J-P: Brachial plexus block and chronic renal failure. Can J Anaesth 34:S118, 1987.
Wyant GM: The anaesthetist looks at tissue transplantation: Three years experience with kidney transplants. Can Anaesth Soc J 14:225–234, 1967.
Lofstrom B: Anaesthetic problems in renal transplantation. J Urol Nephrol 1:161–169, 1967.
Luciani J, Frantz P, Thibault P, Ghesquiere F, Conseiller C, Cousin M-T, Glaser P, LeGrain M, Viars P, Kuss R: Early anuria prevention in human kidney transplantation. Advantages of fluid load under pulmonary artery pressure monitoring during surgical period. Transplantation 28:308–312,1979.
Tiggeler RGWL, Berden JHM, Hoitsma AJ, Koene RAP: Prevention of acute tubular necrosis in cadaveric kidney transplantation by the combined use of mannitol and moderate hydration. Ann Surg 201:246–251, 1985.
Raftery AT, Johnson RWG: Dopamine pretreatment in unstable kidney donors. Br Med J 1:522, 1979.
Parker S, Cardon GC, Isaacs M, Howlands WS, Kahn RC: Dopamine administration in oliguria and oliguric renal failure. Crit Care Med 9:630–632, 1981.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Kluwer Academic Publishers
About this chapter
Cite this chapter
Bevan, D.R. (1991). Anesthesia and Surgery in the Patient with Renal Failure. In: Suki, W.N., Massry, S.G. (eds) Therapy of Renal Diseases and Related Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0689-4_43
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0689-4_43
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8027-9
Online ISBN: 978-1-4613-0689-4
eBook Packages: Springer Book Archive